Free Republic

Abbott, however, strikes back, and it makes things look even worse for the Biden administration. When news of the baby formula shortage first became widely known, one of the main causes, we were told, was that Abbott, the company that manufactures the formula, had put tainted formula onto the marketplace, killing two infants and forcing the FDA to shut down its plant. And indeed, that's exactly what Jen Psaki blamed during her final White House press conference before heading to MSNBC. Abbott, however, pushed back hard, with facts supporting something Psaki knew or should have known: a federal investigation has...

Demand for Abbott Laboratories rapid test for the Coronavirus strain Covid-19 continues to surge while the U.S. Food and Drug Administration reviews the product and more data comes out to support the diagnostic’s accuracy. The FDA last week said it had received 15 adverse event reports about Abbott’s ID NOW Covid-19 test, which has been hailed by the White House, drugstore chains, researchers and clinicians because it can deliver positive results in as little as five minutes and negative results in 13 minutes. As of Friday morning, Abbott said more than 2 million ID NOW rapid molecular tests had been...

Abbott Laboratories is rolling out a new test that can tell whether people have had the novel coronavirus. The test detects antibodies that your body creates to fight off the virus, and Abbott said it'll be able to ship almost 1 million of the tests this week, according to a company announcement. They'll be shipped to laboratories across the country and used with Abbott equipment many of them already possess, according to the company. The machines can run 100-200 tests per hour. Abbott said it plans to be able to produce 4 million tests in April and 20 million in...

The University of Washington School of Medicine’s Virology Lab is reporting encouraging results from trial runs of a new test from Abbott Laboratories that detects the antibodies created by people who have had COVID-19, whether they knew they had it or not. “This is a really fantastic test,” Keith Jerome, who leads UW Medicine’s virology program, told reporters today. He said UW’s lab could process 4,000 samples per day starting next week, and conceivably ramp up to 14,000 samples per day within a couple of weeks. The test will be made available through health care providers, in medical clinics or...

Abbott Laboratories says it is ramping up production of its coronavirus test kits, including a new tool that could enable mass Covid-19 screening, as President Donald Trump seeks to reopen parts of the U.S. economy as early as next month. The company is on track to ship 4 million this month of its new antibody tests, which indicate whether a person has had Covid-19 in the past and was either asymptomatic or recovered, Abbott CEO Robert Ford said during an earnings conference call with investors Thursday. It plans to ramp up to 20 million shipments per month, beginning in June,...

In less than a month, Abbott Laboratories has shipped 566,000 of its highly touted “rapid” molecular tests for the Coronavirus strain COVID-19 to all 50 U.S. states. The effort to get the ID NOW COVID-19 test to doctor’s offices, urgent care centers and temporary testing sites like drive-thru parking lot locations is a snapshot into the massive diagnostic effort under way in the U.S. Abbott’s ID NOW COVID-19 test can deliver “positive results in as little as five minutes and negative results in 13 minutes.” The test, hailed by Donald Trump from the White House and praised by commercial companies...

A quick 5-minute coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic. “That’s a whole new ballgame,” Trump said. “I want to thank Abbott Labs for the incredible work they’ve done. They’ve been working around-the-clock.” Yet a document circulated among officials at the Department of Health and Human Services and the Federal Emergency Management Agency this week shows that state and local public health labs...

Abbott Laboratories is unveiling a coronavirus test that can tell if someone is infected in as little as five minutes, and is so small and portable it can be used in almost any healthcare setting. The medical-device maker plans to supply 50,000 tests a day starting Wednesday, said John Frels, vice president of research and development at Abbott Diagnostics. The molecular test looks for fragments of the coronavirus genome, which can quickly be detected when present at high levels. A thorough search to definitively rule out an infection can take up to 13 minutes, he said. Abbott has received emergency...

CHICAGO – A five-minute, point-of-care coronavirus test could be coming to urgent care clinics next week, and experts say it could be "game-changing." The U.S. Food and Drug Administration issued Emergency Use Authorization to Illinois-based medical device maker Abbott Labs on Friday for a coronavirus test that delivers positive results in as little as five minutes and negative results in 13 minutes, the company said. The company expects the tests to be available next week and expects to ramp up manufacturing to deliver 50,000 tests per day. "I am pleased that the FDA authorized Abbott's point-of-care test yesterday. This is...

- The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines - Test to run on Abbott's point-of-care ID NOW platform - a portable instrument that can be deployed where testing is needed most - ID NOW has the largest molecular point-of-care installed base in the U.S. and is available in a wide range of healthcare settings - Abbott will be making ID NOW COVID-19 tests available next week and expects to ramp up manufacturing to deliver 50,000 tests per day - This is the company's second test to receive Emergency Use Authorization by the FDA for...

Abbott Labs, a global healthcare company, is laying off about 180 IT employees after signing an agreement with Wipro, a major India-based IT services firm, to take over some IT services. The employees were told about the planned cuts on Feb. 22; their last day will be April 22.

MADISON – The campaign of Governor Scott Walker issued a new campaign ad on Monday accusing former Commerce Secretary Mary Burke of a botched deal that may put taxpayers on the hook for $25 million dollars. More: Burke Campaign Issues New Ad over Outsourcing Charge The ad called “Bondoogle” expands off an earlier ad issued by the Walker Campaign that blasted Burke for engaging in a deal with Abbott Laboratories valued at $12.5 million in an attempt to create jobs in Wisconsin. The lot of vacant land that was part of the deal remains vacant to this day according to...

Snips from Excerpt only site: One of the 10 people arrested on Sunday as part of a Russian spy network aimed at infiltrating U.S. policymaking circles appears to have attended the Kennedy School of Government at Harvard University — one of the most influential venues in U.S. policymaking circles. The LinkedIn profile also lists Heathfield as a past partner at Global Partners Inc., a management consulting firm that lists Abbott Labs, Boston Scientific, and GE as clients. Global Partners' website also lists a Donald Heathfield. When Yahoo! News told Carolyn Quintin, one of Heathfield's partners at the firm, of his...

ABBOTT PARK, Ill. -- Abbott Laboratories (ABT, news) reported a 14% increase in third-quarter net income and said it will cut about 2,000 jobs and eliminate 10 facilities, in a move to restructure global manufacturing operations and reorganize its U.S. diagnostics business. The pharmaceuticals giant said the restructuring plans will result in a fourth-quarter charge of $100 million to $125 million to write down manufacturing facilities and for employee severance costs. Abbott expects to see annual savings of $80 million to $100 million by 2005 once the plans are fully implemented. The restructuring also includes the company's international operations. Abbott...